CO7020913A2 - Inhibidores de pde9 con estructura básica de imidazotriazinona - Google Patents

Inhibidores de pde9 con estructura básica de imidazotriazinona

Info

Publication number
CO7020913A2
CO7020913A2 CO14161415A CO14161415A CO7020913A2 CO 7020913 A2 CO7020913 A2 CO 7020913A2 CO 14161415 A CO14161415 A CO 14161415A CO 14161415 A CO14161415 A CO 14161415A CO 7020913 A2 CO7020913 A2 CO 7020913A2
Authority
CO
Colombia
Prior art keywords
imidazotriazinone
basic structure
pde9 inhibitors
pde9
inhibitors
Prior art date
Application number
CO14161415A
Other languages
English (en)
Inventor
Niels Svenstrup
Klaus Baek Simonsen
Lars Kyhn Rasmussen
Karsten Juhl
Morten Langgard
Kate Wen
Yazhou Wang
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CO7020913A2 publication Critical patent/CO7020913A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO14161415A 2012-01-26 2014-07-24 Inhibidores de pde9 con estructura básica de imidazotriazinona CO7020913A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2012070718 2012-01-26
CN2012080208 2012-08-16

Publications (1)

Publication Number Publication Date
CO7020913A2 true CO7020913A2 (es) 2014-08-11

Family

ID=47603775

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14161415A CO7020913A2 (es) 2012-01-26 2014-07-24 Inhibidores de pde9 con estructura básica de imidazotriazinona

Country Status (15)

Country Link
US (3) US9434733B2 (es)
EP (2) EP2807163B1 (es)
CN (2) CN104093720B (es)
AP (1) AP2014007820A0 (es)
AU (2) AU2013213603B2 (es)
BR (1) BR112014018199A8 (es)
CO (1) CO7020913A2 (es)
CR (1) CR20140361A (es)
DO (1) DOP2014000175A (es)
EC (1) ECSP14015609A (es)
HK (1) HK1199879A1 (es)
MX (1) MX351582B (es)
PH (1) PH12014501695B1 (es)
SG (1) SG11201403909RA (es)
WO (1) WO2013110768A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083058A1 (es) 2010-09-20 2013-01-30 Envivo Pharmaceuticals Inc Compuestos de estructura de imidazotriazinona
WO2012047121A1 (en) 2010-10-08 2012-04-12 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
EP2906562B1 (en) 2011-10-10 2016-10-05 H. Lundbeck A/S Pde9i with imidazo pyrazinone backbone
CN104093720B (zh) * 2012-01-26 2017-04-12 H.隆德贝克有限公司 具有咪唑并三嗪酮骨架的pde9抑制剂
EP2828262A4 (en) * 2012-03-19 2015-09-23 Forum Pharmaceuticals Inc IMIDAZOTRIAZINONVERBINDUNGEN
KR20160007347A (ko) 2014-07-11 2016-01-20 에스티팜 주식회사 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도
WO2016006975A2 (en) * 2014-07-11 2016-01-14 St Pharm Co., Ltd. Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
TW201629064A (zh) 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
WO2017000276A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
SI3865484T1 (sl) 2015-07-07 2024-05-31 H. Lundbeck A/S Zaviralec pde9 z imidazo pirazinonsko hrbtenico za zdravljenje perifernih bolezni
CN105669680B (zh) * 2016-03-24 2018-02-23 南京药捷安康生物科技有限公司 吡咯并[2,1‑f][1,2,4]三嗪‑4(1H)‑酮衍生物类PDE9A抑制剂
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
BR112019000005A2 (pt) * 2016-07-06 2019-04-16 H. Lundbeck A/S inibidores de pde9 para o tratamento de doenças periféricas
EP3529250B1 (en) 2016-10-18 2023-12-06 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as pde1 inhibitors
MA46611B1 (fr) 2016-10-28 2020-08-31 H Lundbeck As Traitements combinés comprenant des imidazopyrazinones pour le traitement de troubles psychiatriques et/ou cognitifs
CA3041595A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones
PT3541784T (pt) * 2016-11-18 2023-11-22 Integrative Res Laboratories Sweden Ab Novos derivados de azetidina úteis como moduladores da neurotransmissão catecolaminérgica cortical
KR102643197B1 (ko) * 2017-02-23 2024-03-06 베링거 인겔하임 인터내셔날 게엠베하 화합물 iii의 새로운 의학 용도
TWI843393B (zh) 2017-05-26 2024-05-21 美商卡杜隆製藥公司 製備和使用pde9抑制劑之方法
CN110003213B (zh) * 2018-01-04 2021-10-08 南京农业大学 苯并咪唑并三嗪酮类化合物、制备方法及应用
MX2020007066A (es) 2018-01-05 2020-09-09 Dicerna Pharmaceuticals Inc Reduccion de la expresion de beta-catenina e ido para potenciar la inmunoterapia.
BR112020024019A2 (pt) 2018-05-25 2021-02-23 Imara Inc. monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
EP3965768A1 (en) * 2019-05-07 2022-03-16 Imara Inc. Pde9 inhibitors for treating thalassemia
CN113072556B (zh) * 2021-03-30 2022-02-01 牡丹江医学院 一种用于治疗胶质瘤的药物及其制备方法
WO2024107445A1 (en) * 2022-11-15 2024-05-23 Freedom Biosciences, Inc. Enhancement of the efficacy of serotonergic psychedelic drugs in the treatment or prevention of certain neuropsychiatric disorders through inhibition of type-9 phosphodiesterases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23063A3 (es) 1997-11-12 2005-07-19 Bayer Ag Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
SK10322001A3 (sk) 1999-01-20 2002-07-02 Arzneimittelwerk Dresden Gmbh Spôsob prípravy imidazo [1,5-a]pyrido[3,2-e]pyrazínov, farmaceutické prostriedky obsahujúce takéto zlúčeniny a spôsob výroby farmaceutického prostriedku
KR20040053210A (ko) * 2001-11-02 2004-06-23 화이자 프로덕츠 인크. Pde9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
HN2002000317A (es) 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
GB2388111A (en) 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
US6684626B1 (en) 2002-07-30 2004-02-03 General Electric Company Aircraft gas turbine engine with control vanes for counter rotating low pressure turbines
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
BRPI0416118A (pt) 2003-10-31 2007-01-02 Pfizer Prod Inc inibição da fosfodiesterase 9 como tratamento para estados relacionados com a obesidade
AR053090A1 (es) 2004-07-20 2007-04-25 Osi Pharm Inc Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos
TW200815436A (en) 2006-05-30 2008-04-01 Elbion Ag 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
RS52166B (en) * 2007-05-11 2012-08-31 Pfizer Inc. AMINO-HETEROCYCLIC COMPOUNDS
DE102007032349A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
EA201070725A1 (ru) 2007-12-10 2011-02-28 Глэксо Груп Лимитед Бис-пиридилпиридоны как антагонисты рецептора 1 меланинконцентрирующего гормона
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基-雜環化合物
US20110082147A1 (en) 2009-07-24 2011-04-07 Concert Pharmaceuticals, Inc. Substituted imidazotriazines
US9260432B2 (en) 2009-09-02 2016-02-16 Concert Pharmaceuticals, Inc. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
AR083058A1 (es) * 2010-09-20 2013-01-30 Envivo Pharmaceuticals Inc Compuestos de estructura de imidazotriazinona
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
CN104093720B (zh) 2012-01-26 2017-04-12 H.隆德贝克有限公司 具有咪唑并三嗪酮骨架的pde9抑制剂

Also Published As

Publication number Publication date
CR20140361A (es) 2014-11-11
DOP2014000175A (es) 2014-08-31
EP3178820A1 (en) 2017-06-14
AU2017200886A1 (en) 2017-03-02
CN107082783B (zh) 2019-03-22
AU2017200886B2 (en) 2018-01-18
HK1199879A1 (en) 2015-07-24
SG11201403909RA (en) 2014-10-30
AP2014007820A0 (en) 2014-07-31
PH12014501695A1 (en) 2014-10-20
WO2013110768A1 (en) 2013-08-01
US9434733B2 (en) 2016-09-06
US9533992B2 (en) 2017-01-03
US9850249B2 (en) 2017-12-26
MX351582B (es) 2017-10-20
CN104093720B (zh) 2017-04-12
CN107082783A (zh) 2017-08-22
US20150045348A1 (en) 2015-02-12
EP3178820B1 (en) 2017-12-20
EP2807163A1 (en) 2014-12-03
US20170081333A1 (en) 2017-03-23
AU2013213603A1 (en) 2014-07-24
ECSP14015609A (es) 2015-12-31
MX2014008912A (es) 2014-08-26
EP2807163B1 (en) 2017-03-22
PH12014501695B1 (en) 2014-10-20
US20160213674A1 (en) 2016-07-28
BR112014018199A8 (pt) 2021-03-02
CN104093720A (zh) 2014-10-08
AU2013213603B2 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
CO7020913A2 (es) Inhibidores de pde9 con estructura básica de imidazotriazinona
CO7061086A2 (es) Combinaciones de compuestos activos
DK2917462T3 (da) Brøndisolering
DK3459942T3 (da) DNA-PK-hæmmere
SMT201600114B (it) Inibitori di beta-secretasi
DK3293183T3 (da) Hæmmerforbindelser
DE112012006109A5 (de) Okklusionsschienenanordnung
AR092198A1 (es) Derivados de pirazolopirimidinas
UA25626S (uk) Печиво
FR2987110B1 (fr) Inclinometre
DE112012006214T8 (de) Wulstringwickler
DE112012005566T8 (de) Seltenerdnanoverbundmagnet
FR2987600B1 (fr) Nacelle aplatie de turboreacteur
DK2402077T3 (da) Isolatorenhed
ES1080381Y (es) Fachada de medios
DE102013212400A8 (de) Abdeckplattenstützbaugruppe
FI10031U1 (fi) Seinäteline
FR2997080B1 (fr) Inhibiteurs de neprilysine
DK3354436T3 (da) Isoleringsblok
FI20125291A (fi) Liitinrakenne
DE102012100780A8 (de) Zugmittelhebevorrichtung
FR2955136B1 (fr) Arret de vantail
FR2987258B1 (fr) Kit de biberons
FR3005071B1 (fr) Structure de gabion
FR3005070B1 (fr) Structure de gabion